$ACON
Aclarion, Inc. Stock $acon

$acon Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000168316823001165 Filed on February 27, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$25.47K	$22.52K	$60.44K
YoY Change	182.18%		0.26%
Cost Of Revenue	$17.45K	$17.29K	$65.30K
YoY Change	4.29%		-5.61%
Gross Profit	$8.020K	$5.230K	-$4.854K
YoY Change	-204.07%		-45.4%
Gross Profit Margin	31.49%	23.22%	-8.03%
Selling, General & Admin	$984.9K	$1.092M	$5.005M
YoY Change	75.69%		132.1%
% of Gross Profit	12280.3%	20883.37%
Research & Development	$204.4K	$239.8K	$1.089M
YoY Change	-0.2%		38.2%
% of Gross Profit	2548.63%	4584.7%
Depreciation & Amortization	$39.37K	$51.77K	$4.500K
YoY Change	-16.94%		-97.62%
% of Gross Profit	490.9%	989.87%
Operating Expenses	$1.189M	$1.332M	$6.094M
YoY Change	55.38%		106.98%
Operating Profit	-$1.181M	-$1.327M	-$6.099M
YoY Change	52.8%		106.52%
Interest Expense	-$1.380K	-$2.070K	$1.508M
YoY Change	-100.85%		-163.43%
% of Operating Profit
Other Income/Expense, Net	-$820.00	-$80.00	-$1.507M
YoY Change	228.0%		-26218.3%
Pretax Income	-$1.183M	-$1.329M	-$7.606M
YoY Change	26.43%		53.64%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$1.183M	-$1.329M	-$7.606M
YoY Change	26.43%		53.64%
Net Earnings / Revenue	-4646.49%	-5901.02%	-12582.79%
Basic Earnings Per Share	-$0.15		-$1.31
Diluted Earnings Per Share	-$0.15	-$0.17	-$1.31
COMMON SHARES
Basic Shares Outstanding	7.862M shares	7.822M shares	6.106M shares
Diluted Shares Outstanding	7.939M shares		6.106M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$450.0K	$1.473M	$1.473M
YoY Change	791.97%		225.46%
Cash & Equivalents	$458.0K	$1.473M	$1.473M
Short-Term Investments
Other Short-Term Assets	$210.0K	$496.9K	$496.9K
YoY Change	-58.21%		81.74%
Inventory
Prepaid Expenses
Receivables	$17.15K	$18.57K	$18.57K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$675.5K	$1.988M	$1.988M
YoY Change	19.46%	171.54%	171.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.843K	$3.346K	$3.350K
YoY Change	-73.96%	-73.52%	-73.5%
Goodwill
YoY Change
Intangibles	$1.183M	$1.214M
YoY Change		6.09%
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change
Total Long-Term Assets	$1.186M	$1.218M	$1.218M
YoY Change	-4.56%	5.22%	5.22%
TOTAL ASSETS
Total Short-Term Assets	$675.5K	$1.988M	$1.988M
Total Long-Term Assets	$1.186M	$1.218M	$1.218M
Total Assets	$1.861M	$3.206M	$3.206M
YoY Change	2.96%	69.68%	69.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$544.7K	$462.2K	$457.6K
YoY Change	-60.73%	-56.61%	-56.82%
Accrued Expenses	$190.0K	$610.8K	$610.8K
YoY Change	-84.18%		-12.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$736.4K	$1.418M	$1.418M
YoY Change	-91.57%	-81.39%	-81.39%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$736.4K	$1.418M	$1.418M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$740.0K	$1.418M	$1.418M
YoY Change	-91.53%	-81.39%	-81.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$40.55M	-$39.91M
YoY Change	22.48%	25.16%
Common Stock	$79.00	$79.00
YoY Change	777.78%	777.78%
Preferred Stock		$0.00
YoY Change		-100.0%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.125M	$1.788M	$1.788M
YoY Change
Total Liabilities & Shareholders Equity	$1.861M	$3.206M	$3.206M
YoY Change	2.96%	69.68%	69.68%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.183M	-$1.329M	-$7.606M
YoY Change	26.43%		53.64%
Depreciation, Depletion And Amortization	$39.37K	$51.77K	$4.500K
YoY Change	-16.94%		-97.62%
Cash From Operating Activities	-$1.013M	-$1.135M	-$5.314M
YoY Change	290.52%		126.14%
INVESTING ACTIVITIES
Capital Expenditures	$11.72K	$48.25K	$208.9K
YoY Change	-108.84%		-237.41%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$1.000K
YoY Change
Cash From Investing Activities	-$11.72K	-$48.25K	-$207.9K
YoY Change	-91.16%		36.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	$6.552M
YoY Change			122.91%
NET CHANGE
Cash From Operating Activities	-1.013M	-1.135M	-$5.314M
Cash From Investing Activities	-11.72K	-48.25K	-$207.9K
Cash From Financing Activities	0.000	0.000	$6.552M
Net Change In Cash	-1.025M	-1.183M	$1.030M
YoY Change	161.38%		135.47%
FREE CASH FLOW
Cash From Operating Activities	-$1.013M	-$1.135M	-$5.314M
Capital Expenditures	$11.72K	$48.25K	$208.9K
Free Cash Flow	-$1.025M	-$1.183M	-$5.523M
YoY Change	708.37%		151.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001635077
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	ACON	Issuance Of Preferred Shares IssuanceOfPreferredShares		usd
CY2022	ACON	Issuance Of Preferred Shares IssuanceOfPreferredShares		usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41358
CY2022	dei	Entity Registrant Name EntityRegistrantName	ACLARION, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3324725
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	8181 Arista Place
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Broomfield
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80021
CY2022	dei	City Area Code CityAreaCode	(833)
CY2022	dei	Local Phone Number LocalPhoneNumber	275-2266
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	5019673	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7861515	shares
CY2022	dei	Auditor Name AuditorName	Daszkal Bolton LLP
CY2022	dei	Auditor Location AuditorLocation	Fort Lauderdale, Florida
CY2022	dei	Auditor Firm AuditorFirmId	229
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1472806	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	432530	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	10000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	20000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18569	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6280	usd
CY2022Q4	ACON	Deferred Compensation Asset Current DeferredCompensationAssetCurrent	291331	usd
CY2021Q4	ACON	Deferred Compensation Asset Current DeferredCompensationAssetCurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	195534	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	273394	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1988240	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	732204	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3346	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12636	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1214374	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1144625	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1217720	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1157261	usd
CY2022Q4	us-gaap	Assets Assets	3205961	usd
CY2021Q4	us-gaap	Assets Assets	1889465	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	462202	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1065304	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	610765	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	696582	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2000000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	3856898	usd
CY2022Q4	ACON	Liability To Issue Equity LiabilityToIssueEquity	345243	usd
CY2021Q4	ACON	Liability To Issue Equity LiabilityToIssueEquity	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1418209	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7618784	usd
CY2022Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	0	usd
CY2021Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	7102229	usd
CY2022Q4	ACON	Redeemable Preferred Stock Value RedeemablePreferredStockValue	0	usd
CY2021Q4	ACON	Redeemable Preferred Stock Value RedeemablePreferredStockValue	7102287	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7861515	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7861515	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	905685	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	905685	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	79	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	41694774	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19054234	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39907101	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31886036	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1787751	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12831606	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3205961	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1889465	usd
CY2022	us-gaap	Revenues Revenues	60444	usd
CY2021	us-gaap	Revenues Revenues	60292	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	65298	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	69175	usd
CY2022	us-gaap	Gross Profit GrossProfit	-4854	usd
CY2021	us-gaap	Gross Profit GrossProfit	-8883	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	537069	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	330814	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1088778	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	787850	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4467815	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1825491	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6093662	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	2944155	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6098516	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2953038	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	373511	usd
CY2022	us-gaap	Interest Expense InterestExpense	1507546	usd
CY2021	us-gaap	Interest Expense InterestExpense	474911	usd
CY2022	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	0	usd
CY2021	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	-1900310	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	520	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4458	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1507026	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1997252	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7605542	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-4950290	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7605542	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4950290	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	415523	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1005598	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8021064	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5955888	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.31
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.58
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.58
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6105569	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6105569	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	905685	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	905685	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-7083601	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	30393	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1005597	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	177489	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4950290	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12831606	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12831606	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1280	usd
CY2022	ACON	Exercise Of Convertible Note Warrants Value ExerciseOfConvertibleNoteWarrantsValue	152653	usd
CY2022	ACON	Dividends Preferred Stock Payable DividendsPreferredStockPayable	3856898	usd
CY2022	ACON	Conversion Of Preferred Stock To Common Stock Value ConversionOfPreferredStockToCommonStockValue	7102287	usd
CY2022	ACON	Conversion Of Accrued Interest On Promissory Notes Value ConversionOfAccruedInterestOnPromissoryNotesValue	1855158	usd
CY2022	ACON	Issuance Of Common Stock And Warrants Related To Ipo Value IssuanceOfCommonStockAndWarrantsRelatedToIPOValue	8552340	usd
CY2022	ACON	Adjustments To Additional Paid In Capital Other Ipo Issuance Costs AdjustmentsToAdditionalPaidInCapitalOtherIPOIssuanceCosts	-530463	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	102000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1132747	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7605542	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1787751	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7605542	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4950290	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	193621	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	186388	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1186659	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	177489	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	102000	usd
CY2022	ACON	Warrants Issued As Noncash Finance Charge WarrantsIssuedAsNoncashFinanceCharge	0	usd
CY2021	ACON	Warrants Issued As Noncash Finance Charge WarrantsIssuedAsNoncashFinanceCharge	30393	usd
CY2022	ACON	Gain On Forgiveness Of Ppp Loans GainOnForgivenessOfPPPLoans	-0	usd
CY2021	ACON	Gain On Forgiveness Of Ppp Loans GainOnForgivenessOfPPPLoans	373511	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3789	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
CY2022	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	-0	usd
CY2021	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	-1900310	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12290	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16222	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	267383	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	210765	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-603102	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	199604	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1487363	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	509806	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	200712	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	114404	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5314171	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2399949	usd
CY2022	us-gaap	Proceeds From Sale Of Furniture And Fixtures ProceedsFromSaleOfFurnitureAndFixtures	1000	usd
CY2021	us-gaap	Proceeds From Sale Of Furniture And Fixtures ProceedsFromSaleOfFurnitureAndFixtures	0	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	208870	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	102005	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-207870	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-102005	usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	0	usd
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	125000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	814500	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2000000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2000000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-0	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	8552318	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6552318	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2939500	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1030276	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	437546	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	452530	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14984	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1482806	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	452530	usd
CY2022	ACON	Conversion Of Indebtedness To Preferred Equity Commitment ConversionOfIndebtednessToPreferredEquityCommitment	0	usd
CY2021	ACON	Conversion Of Indebtedness To Preferred Equity Commitment ConversionOfIndebtednessToPreferredEquityCommitment	5201977	usd
CY2022	ACON	Dividends Accrued On Preferred Shares DividendsAccruedOnPreferredShares	415523	usd
CY2021	ACON	Dividends Accrued On Preferred Shares DividendsAccruedOnPreferredShares	1005598	usd
CY2022	ACON	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	25754379	usd
CY2021	ACON	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	0	usd
CY2022	ACON	Conversion Of Preferred Stock Dividends To Common Stock ConversionOfPreferredStockDividendsToCommonStock	4272420	usd
CY2021	ACON	Conversion Of Preferred Stock Dividends To Common Stock ConversionOfPreferredStockDividendsToCommonStock	0	usd
CY2022	ACON	Conversion Of Accrued Interest On Promissory Notes To Common Stock And Warrants ConversionOfAccruedInterestOnPromissoryNotesToCommonStockAndWarrants	1856438	usd
CY2021	ACON	Conversion Of Accrued Interest On Promissory Notes To Common Stock And Warrants ConversionOfAccruedInterestOnPromissoryNotesToCommonStockAndWarrants	0	usd
CY2022	ACON	Issuance Of Underwriters Warrants Related To Ipo IssuanceOfUnderwritersWarrantsRelatedToIpo	74677	usd
CY2021	ACON	Issuance Of Underwriters Warrants Related To Ipo IssuanceOfUnderwritersWarrantsRelatedToIpo	0	usd
CY2022	ACON	Change In Fair Value Of Redeemable Preferred Stock ChangeInFairValueOfRedeemablePreferredStock	0	usd
CY2021	ACON	Change In Fair Value Of Redeemable Preferred Stock ChangeInFairValueOfRedeemablePreferredStock	1900310	usd
CY2022	ACON	Liability To Issue Common Shares LiabilityToIssueCommonShares	345243	usd
CY2021	ACON	Liability To Issue Common Shares LiabilityToIssueCommonShares	0	usd
CY2022Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-7.47 reverse stock split
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_ziaVwwxkhOBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86F_zxlC20Hzfcj4">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements include some amounts that are based on management's best estimates and judgments. The most significant estimates relate to depreciation, amortization, valuation of capital stock, and valuation of warrants and options to purchase shares of the Company's preferred and common stock. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zbD2tUlrrf6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_862_zOAm3N3nDYzf">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain accounts relating to the prior year have been reclassified to conform to the current period’s presentation. These reclassifications had no effect on the net income or net assets as previously reported.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1229000	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	201000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	10000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1500000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18569	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6280	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	457558	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1059546	usd
CY2022Q4	ACON	Credit Cards Payable CreditCardsPayable	4644	usd
CY2021Q4	ACON	Credit Cards Payable CreditCardsPayable	5758	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	610765	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	340363	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	356219	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1072967	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1761886	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	520	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4458	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	36070	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	64932	usd
CY2022	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	26340	usd
	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	48400	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	73372	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	113227	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70026	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	100591	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3346	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12636	usd
CY2022	us-gaap	Depreciation Depreciation	4500	usd
CY2021	us-gaap	Depreciation Depreciation	12981	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	usd
CY2022Q4	ACON	Future Depreciation Of Property And Equipment In Next Tweleve Months FutureDepreciationOfPropertyAndEquipmentInNextTweleveMonths	1563	usd
CY2022Q4	ACON	Future Depreciation Of Property And Equipment In Year Two FutureDepreciationOfPropertyAndEquipmentInYearTwo	1187	usd
CY2022Q4	ACON	Future Depreciation Of Property And Equipment In Year Three FutureDepreciationOfPropertyAndEquipmentInYearThree	596	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3346	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2352746	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2093875	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1138372	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-949250	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1214374	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1144625	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	189121	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	176390	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q3	us-gaap	Share Price SharePrice	1.94
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.87
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2738820	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.94
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y4M24D
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8021064	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5955888	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6105569	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6105569	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	905685	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	905685	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5681610	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3621932	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2255672	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.84
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	533349	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.30
CY2021	ACON	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Options Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2OptionsGranted	P9Y7M6D
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	50201	shares
CY2021	ACON	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Options Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2OptionsForfeited	P5Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2738820	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.94
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2169088	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	559414	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	481915	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.82
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	61826	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.87
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	420089	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.82
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	53912	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	40000	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	102000	usd

Files In Submission

Name	View Source	Status
acon-20221231_cal.xml	Edgar Link	unprocessable
acon-20221231_pre.xml	Edgar Link	unprocessable
0001683168-23-001165-index-headers.html	Edgar Link	pending
0001683168-23-001165-index.html	Edgar Link	pending
0001683168-23-001165.txt	Edgar Link	pending
0001683168-23-001165-xbrl.zip	Edgar Link	pending
aclarion_ex2301.htm	Edgar Link	pending
aclarion_ex3101.htm	Edgar Link	pending
aclarion_ex3102.htm	Edgar Link	pending
aclarion_ex3201.htm	Edgar Link	pending
aclarion_ex3202.htm	Edgar Link	pending
aclarion_i10k-123122.htm	Edgar Link	pending
acon-20221231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
acon-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
acon-20221231_lab.xml	Edgar Link	unprocessable
aclarion_i10k-123122_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACON
Aclarion, Inc. Stock $acon

2023 Q1 Form 10-K Financial Statement

#000168316823001165 Filed on February 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACON Aclarion, Inc. Stock $acon

2023 Q1 Form 10-K Financial Statement

#000168316823001165 Filed on February 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACON
Aclarion, Inc. Stock $acon